Market›Health Care›Health Care Equipment & Supplies›Health Care Equipment
DAXOR CORP

DXR

$10.25Apr 26, 2021 – Apr 24, 2026
Health CareHealth Care Equipment & SuppliesHealth Care Equipment$55M
MVM
+$1.2M
TD Variance
1.333

Every news event mapped to its market reaction — 61 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2021-06-04+45.6%newsSeeking AlphaWPG leads financial gainers, AINC and SRAC among losers
2023-05-22-20.6%newsSeeking AlphaDaxor shares tumble after pricing stock offering at discount
2022-11-15-18.9%newsSeeking AlphaDaxor to raise $2M in stock offering
2022-11-14-16.8%newsSeeking AlphaDaxor tumbles 11% aftermarket on proposed stock offering
2026-01-23-10.9%legalSEC EDGARDXR 8-K: 8.01 and (SEC Filing)
2026-01-23-10.9%newsStock TitanDaxor to raise $9M in new stock sale at $11.75 a share - Stock Titan
2026-04-06-9.1%newsXã Vĩnh CôngCan Daxor (DXR) Stock Double in 2026 | Price at $9.16, Down 5.52% - Quantitative Analysis - Xã Vĩnh Công
2026-04-06-9.1%newsXã Thanh HàCan Daxor (DXR) Stock Double in 2026 | Price at $9.16, Down 5.52% - Micro Trends - Xã Thanh Hà
2023-10-27-9.0%legalSEC EDGARDXR 8-K: 8.01 (SEC Filing)
2022-07-21-6.7%newsSeeking AlphaDaxor partners with Medaxiom to advance awareness of blood volume diagnostic
2025-06-29+6.5%legalStock TitanDXR SEC Filings - DAXOR CORP 10-K, 10-Q, 8-K Forms - Stock Titan
2024-01-02+5.9%legalSEC EDGARDXR 8-K: 8.01 and (SEC Filing)
2026-03-31-5.7%executiveInvesting.comMichel, Daxor CFO, buys $9,900 in DXR stock - Investing.com
2026-03-31-5.7%executiveStock TitanDAXOR CORP (DXR) CFO adds 1,000 shares in open-market buy - Stock Titan
2022-08-25-5.5%earningsSeeking AlphaDaxor reports Q2 results
2022-08-26-5.3%earningsSeeking AlphaDaxor Corporation (DXR) Q2 2022 Earnings Call Transcript
2022-01-04+4.7%earningsSeeking AlphaDaxor gets US patent for blood volume guidance technology
2022-02-02+4.3%legalSEC EDGARDXR 8-K: 8.01 and (SEC Filing)
2022-01-24-4.3%legalSEC EDGARDXR 8-K: 5.02 (SEC Filing)
2024-03-25+4.3%M&ASeeking AlphaDaxor acquires Volumex and Megatope from existing supplier
2024-03-25+4.3%legalSEC EDGARDXR 8-K: 8.01 and (SEC Filing)
2021-10-01-4.1%expansionSeeking AlphaDaxor receives $200K in matching fund award from Launch Tennessee
2024-03-26-4.0%earningsSeeking AlphaDaxor Corporation (DXR) Q4 2023 Earnings Call Transcript
2021-08-30+3.9%newsSeeking AlphaDaxor reports 1H results
2025-06-26-3.8%legalStock TitanDXR SEC Filings - DAXOR CORP 10-K, 10-Q, 8-K Forms - Stock Titan
2022-11-21-3.6%legalSEC EDGARDXR 8-K: 8.01 and (SEC Filing)
2026-02-10+3.1%newsStock TitanBlood volume test firm Daxor to adopt 1934 rules for clearer investor reports - Stock Titan
2026-04-08+2.8%newsGlobeNewswireDaxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Center
2026-04-08+2.8%newsStock Titan24-hour blood volume testing reaches Ohio heart failure center - Stock Titan
2022-07-27-2.8%earningsSeeking AlphaDaxor says Q2 sales of single-use diagnostic kits up nearly 50% Y/Y
2025-05-27+2.5%newsIntellectia AIDXR Forecast — Price Prediction for 2026. Should I Buy DXR? - Intellectia AI
2026-03-03+2.5%executiveGlobeNewswireDaxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
2026-03-03+2.5%newsSeeking AlphaDaxor reports FY results
2026-03-03+2.5%legalStock Titan7-pound blood volume analyzer wins FDA clearance, gains hospital users - Stock Titan
2021-05-06-2.1%legalSEC EDGARDXR 8-K: 8.01 and (SEC Filing)
2026-03-15-2.0%legalMarketBeatDaxor Details Portable FDA-Cleared Blood Volume Analyzer, 'Razor-and-Blades' Kit Growth at iAccess Alpha
2025-03-07+1.9%earningsSeeking AlphaDaxor Corporation (DXR) Q4 2024 Earnings Call Transcript
2023-11-28-1.8%legalSEC EDGARDXR 8-K: 8.01 (SEC Filing)
2025-07-21+1.8%newsSeeking AlphaDaxor declares $0.0432 dividend
2023-05-26-1.6%legalSEC EDGARDXR 8-K: 8.01 and (SEC Filing)
2026-03-24-1.4%M&AInvesting.comDaxor (DXR) chief medical officer Jefferies acquires shares worth $0 - Investing.com
2026-03-24-1.4%newsStock TitanDaxor (DXR) CMO boosts stake with 5,941-share equity grant - Stock Titan
2026-03-17-1.2%earningsGlobeNewswireDaxor Corporation to Showcase Next-Generation Portable Blood Volume Analyzer at ACC.26; Highlighting Clinical Outcomes and Reduced Readmissions
2026-03-26+1.1%newsGlobeNewswireDaxor’s Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026
2026-03-26+1.1%newsStock TitanCommon leak scores stayed low while Daxor measured 20% hourly leak - Stock Titan
2026-03-10+1.0%newsACCESS NewswireUpdated Lineup Announced for the iAccess Alpha Virtual Best Ideas Spring Investment Conference March 10-11, 2026
2026-03-10+1.0%newsGlobeNewswireDaxor to Debut New Rapid, Portable Blood Volume Analyzer at SCCM 2026 Critical Care Congress
2026-03-10+1.0%newsSeeking AlphaDaxor Corporation (DXR) Presents at IAccess Alpha Virtual Best Ideas Spring Investment Conference 2026 Prepared Remarks Transcript
2023-07-05+0.8%expansionSeeking AlphaDaxor gets $1.1M contract from the US Defense Health Agency
2024-06-05+0.8%executiveSeeking AlphaDaxor names John Jefferies as chief medical officer
2026-04-20-0.7%newsCNW GroupDynamic announces April 2026 cash distributions for Dynamic Active ETFs and ETF Series
2026-04-10-0.6%executiveStock TitanDAXOR (DXR) CEO Michael Feldschuh adds 1,000 shares in open-market buy - Stock Titan
2023-03-06+0.6%earningsSeeking AlphaDaxor Corporation (DXR) Q4 2022 Earnings Call Transcript
2022-04-06+0.5%newsSeeking AlphaDaxor blood volume test BVA-100 shows accuracy for heart condition in new study
2025-08-07-0.5%legalSEC EDGARDXR 8-K: 8.01 and (SEC Filing)
2026-03-19+0.4%newsCNW GroupDynamic announces March 2026 cash distributions for Dynamic Active ETFs and ETF Series
2022-03-01-0.3%newsSeeking AlphaDaxor reports FY results
2026-03-09+0.2%newsGlobeNewswireDaxor Corporation to Participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conference 2026
2026-03-09+0.2%newsGlobeNewswireDaxor Corporation to Participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conference 2026 - GlobeNewswire
2026-01-26+0.1%legalSEC EDGARDXR 8-K: 1.01, 8.01 (SEC Filing)
2026-04-25—newsStock Traders DailyHow Daxor Corporation (DXR) Affects Rotational Strategy Timing - Stock Traders Daily
tickerdossier.comtickerdossier.substack.com